First report of molecular diagnosis of Tunisian hemophiliacs A: identification of 8 novel causative mutations
- PMID: 22883072
- PMCID: PMC3487796
- DOI: 10.1186/1746-1596-7-93
First report of molecular diagnosis of Tunisian hemophiliacs A: identification of 8 novel causative mutations
Abstract
Introduction: Hemophilia A is an X linked recessive hemorrhagic disorder caused by mutations in the F8 gene that lead to qualitative and/or quantitative deficiencies of coagulation factor VIII (FVIII). Molecular diagnosis of hemophilia A is challenging because of the high number of different causative mutations that are distributed throughout the large F8 gene. Molecular studies of these mutations are essential in order to reinforce our understanding of their pathogenic effect responsible for the disorder.
Aim: In this study we have performed molecular analysis of 28 Tunisian hemophilia A patients and analyzed the F8 mutation spectrum.
Methods: We screened the presence of intron 22 and intron 1 inversion in severe hemophilia A patients by southern blotting and polymerase chain reaction (PCR). Detection of point mutations was performed by dHPLC/sequencing of the coding F8 gene region. We predict the potential functional consequences of novel missense mutations with bioinformatics approaches and mapping of their spatial positions on the available FVIII 3D structure.
Results: We identified 23 different mutations in 28 Tunisian hemophilia A patients belonging to 22 unrelated families. The identified mutations included 5 intron 22 inversions, 7 insertions, 4 deletions and 7 substitutions. In total 18 point mutations were identified, of which 9 are located in exon 14, the most mutated exonic sequence in the F8 gene. Among the 23 mutations, 8 are novel and not deposited in the HAMSTeRS database nor described in recently published articles.
Conclusion: The mutation spectrum of Tunisian hemophilia A patients is heterogeneous with the presence of some characteristic features.
Virtual slides: The virtual slide(s) for this article can be found here:http://www.diagnosticpathology.diagnomx.eu/vs/1693269827490715.
Figures



Similar articles
-
A possible mechanism for Inv22-related F8 large deletions in severe hemophilia A patients with high responding factor VIII inhibitors.J Thromb Haemost. 2012 Oct;10(10):2099-107. doi: 10.1111/j.1538-7836.2012.04897.x. J Thromb Haemost. 2012. PMID: 22906111
-
Identification of seven novel mutations in the factor VIII gene in 18 unrelated Chinese patients with hemophilia A.Chin Med J (Engl). 2010 Feb 5;123(3):305-10. Chin Med J (Engl). 2010. PMID: 20193250
-
[Introns 1 and 22 inversions and F8 gene sequencing for molecular diagnosis of hemophilia A in Chile].Rev Med Chil. 2011 Feb;139(2):189-96. Epub 2011 Jul 11. Rev Med Chil. 2011. PMID: 21773656 Spanish.
-
The Canadian "National Program for hemophilia mutation testing" database: a ten-year review.Am J Hematol. 2013 Dec;88(12):1030-4. doi: 10.1002/ajh.23557. Epub 2013 Sep 9. Am J Hematol. 2013. PMID: 23913812 Review.
-
F8 inversions of introns 22 and 1 confer a moderate risk of inhibitors in Mexican patients with severe hemophilia A. Concordance analysis and literature review.Blood Cells Mol Dis. 2018 Jul;71:45-52. doi: 10.1016/j.bcmd.2018.02.003. Epub 2018 Feb 23. Blood Cells Mol Dis. 2018. PMID: 29544691 Review.
Cited by
-
Deletion mutation in BSCL2 gene underlies congenital generalized lipodystrophy in a Pakistani family.Diagn Pathol. 2013 May 9;8:78. doi: 10.1186/1746-1596-8-78. Diagn Pathol. 2013. PMID: 23659685 Free PMC article.
-
Molecular Analysis of Factor VIII and Factor IX Genes in Hemophilia Patients: Identification of Novel Mutations and Molecular Dynamics Studies.J Clin Med Res. 2017 Apr;9(4):317-331. doi: 10.14740/jocmr2876w. Epub 2017 Feb 21. J Clin Med Res. 2017. PMID: 28270892 Free PMC article.
-
Spectrum of Genetic Diseases in Tunisia: Current Situation and Main Milestones Achieved.Genes (Basel). 2021 Nov 19;12(11):1820. doi: 10.3390/genes12111820. Genes (Basel). 2021. PMID: 34828426 Free PMC article.
-
Frequency of Intron 22 Inversion in Severe Hemophilia A Patients.Cureus. 2022 Aug 21;14(8):e28247. doi: 10.7759/cureus.28247. eCollection 2022 Aug. Cureus. 2022. PMID: 36158401 Free PMC article.
-
Factor VIII Intron 22 Inversion in Severe Hemophilia A Patients in Palestine.Scientifica (Cairo). 2020 Sep 25;2020:3428648. doi: 10.1155/2020/3428648. eCollection 2020. Scientifica (Cairo). 2020. PMID: 33062376 Free PMC article.
References
-
- Zimmermann MA, Oldenburg J, Müller CR, Rost S. Unusual genomic rearrangements in introns 1 and 22 of the F8 gene. Hamostaseologie. 2011;31:69–73. - PubMed
-
- Antonarakis SE, Rossiter JP, Young M. et al.Factor VIII gene inversions in severe hemophilia A: results of an international consortium study. Blood. 1995;86:2206–2212. - PubMed
-
- Gouw SC, Van Der Bom JG, Van Den Berg HM, Zewald RA, Ploos Van Amstel JK, Mauser-Bnschoten EP. Influence of the type of F8 gene mutation on inhibitor development in a single centre cohort of severe haemophilia A patients. Haemophilia. 2011;17:275–281. doi: 10.1111/j.1365-2516.2010.02420.x. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous